Back to results
US 6,333,160 B1Granted
Method and specific diagnostic system for objectively assessing and monitoring the relative homeostasis and health of animals
OwnerKeiji Tamurainventor
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
OwnerKeiji Tamurainventor
Estimating the term…
A method for objectively assessing and monitoring the relative health and homeostatic balance of a group of animals or the individual animals in the group as a basis for animal management decisions is provided. The objective assessment and monitoring method quantitatively determines the upper limit of normal for α1-acid glycoprotein values in a selected body fluid of a selected species of animals. The α1-acid glycoprotein levels of the animals to be evaluated are quantitatively determined and compared with the normal α1-acid glycoprotein upper limit to identify animals whose immune systems or health has been compromised by stress or disease to provide a basis for animal management decisions to promote and maintain the optimum health and well being of the group.
A method for controlling the health of a group of animals and maintaining the group of animals in a condition of optimum health to maximize the productivity of the animals in the group, comprising the steps of
A method for evaluating the health status of a group of a selected species of animals whose health status is unknown to determine the health of the group, comprising the steps of
A method for managing a group of commercially marketable animals to insure that the animals comprising said group are healthy and remain healthy and commercially marketable, said method including monitoring the α1-acid glycoprotein values in a selected body fluid of said animals, comparing said α1-acid glycoprotein values to a normal α1-acid glycoprotein upper limit determined for the selected body fluid in healthy animals of the same species as said group to identify individual animals with α1-acid glycoprotein values above said normal upper limit, determining the cause of the elevated α1-acid glycoprotein levels, treating said animals as indicated by said cause, monitoring the α1-acid glycoprotein levels of said animals undergoing treatment, and stopping said indicated treatment when the α1-acid glycoprotein levels of said treated animals are demonstrated to be normal.
A method for maintaining the quality of products obtained from a group of animals at an acceptable level, comprising the steps of
Dependencies are inferred from the claim text.